Globus Medical (GMED) Cash from Investing Activities (2011 - 2026)

Globus Medical (GMED) has reported Cash from Investing Activities for 16 consecutive years, with -$129.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Cash from Investing Activities rose 56.86% year-over-year to -$129.0 million; the trailing twelve-month figure through Jun 2026 stood at -$499.0 million (down 73.99% YoY), and the FY2025 full-year result was -$355.0 million, down 101.65% from the prior year.
• Cash from Investing Activities improved to -$129.0 million in Q2 2026 per GMED's latest filing, from -$182.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $320.6 million in Q4 2023 and bottomed at -$299.1 million in Q2 2025.
• Historically, Cash from Investing Activities has averaged -$36.1 million across 5 years, with a median of -$53.5 million in 2022.
• The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities soared 19069.23% in 2022, then plunged 2782.14% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$60.5 million in 2022, then jumped by 630.08% to $320.6 million in 2023, then plunged by 132.48% to -$104.1 million in 2024, then slipped by 7.04% to -$111.4 million in 2025, then declined by 15.79% to -$129.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$129.0 million, -$182.7 million, and -$111.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.